Items Tagged ‘squamous cell cancer’

June 8th, 2016

Long-Lasting Responses Achieved with Keytruda® in Advanced Head and Neck Cancer

By

Treatment with the immune-stimulating agent, Keytruda® (pembrolizumab), provides impressive long-term outcomes for some patients with metastatic or recurrent head and neck cancer. These results were recently presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO). Globally, head and neck cancer comprises the seventh most common type of cancer with an […]

View full entry

Tags: advanced, ASCO 2016, General Head and Neck Cancer, Head and Neck Cancer, HNSCC, KEYNOTE-012, keytruda, metastatic, News, perbrolizumab, squamous cell cancer